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outcome to matched dichorionic twins. MATERIAL AND METHODS: Among the 57 women treated
at a single fetal treatment center between 2008 and 2017 with FLS because of twin-to-twin transfusion
syndrome, 25 women with 42 children were included in the FLS group. The control group consisted of 16
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outcome was assessed by a parental questionnaire and a standardized neurodevelopmental examination
for children born before 32 gestational weeks or with a birth weight lower than 1500 g. They were also
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defined as normal neurology, behavior, vision, and hearing. The secondary outcomes were school career,
need for therapy and special aid equipment, and free-time activities. RESULTS: An event-free survival
was found in 32 children (76%) in the laser and in 24 children (75%) in the control group (p = 0.91).
Neurological anomalies were found in 5 children (12%) in the laser group and 3 children (9%) in the
control group (p = 1.00). Multiple logistic regression analysis showed that GA at delivery was the only
predictive factor for event-free survival. There were no significant differences regarding school career,
therapies, or special aid equipment between the 2 groups. We found that children without FLS were
involved in more free-time activities and needed fewer breaks during physical activity than children
with FLS during pregnancy. CONCLUSION: The outcome of monochorionic twins treated with FLS is
comparable to the outcome of dichorionic twins. Long-term neurodevelopment in the cohort was mainly
dependent on GA at birth.
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Abstract
Introduction: The only causal therapy is fetoscopic laser sur-
gery (FLS). The aims of this study were to analyze the long-
term outcome of monochorionic twins treated by FLS, in-
cluding their school career, need for therapy and special aid 
equipment, and free-time activities, and compare their out-
come to matched dichorionic twins. Material and Methods: 
Among the 57 women treated at a single fetal treatment 
center between 2008 and 2017 with FLS because of twin-to-
twin transfusion syndrome, 25 women with 42 children 
were included in the FLS group. The control group consisted 
of 16 dichorionic twin pairs matched for birth year, gesta-
tional age (GA), birth weight, and sex. The long-term out-
come was assessed by a parental questionnaire and a stan-
dardized neurodevelopmental examination for children 
born before 32 gestational weeks or with a birth weight low-
er than 1500 g. They were also registered into the Swiss Neo-
natal Network database. The primary outcome was event-
free survival, defined as normal neurology, behavior, vision, 
and hearing. The secondary outcomes were school career, 
need for therapy and special aid equipment, and free-time 
activities. Results: An event-free survival was found in 32 
children (76%) in the laser and in 24 children (75%) in the 
control group (p = 0.91). Neurological anomalies were found 
in 5 children (12%) in the laser group and 3 children (9%) in 
the control group (p = 1.00). Multiple logistic regression 
analysis showed that GA at delivery was the only predictive 
factor for event-free survival. There were no significant dif-
ferences regarding school career, therapies, or special aid 
equipment between the 2 groups. We found that children 
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without FLS were involved in more free-time activities and 
needed fewer breaks during physical activity than children 
with FLS during pregnancy. Conclusion: The outcome of 
monochorionic twins treated with FLS is comparable to the 
outcome of dichorionic twins. Long-term neurodevelop-
ment in the cohort was mainly dependent on GA at birth.
© 2020 The Author(s)
Published by S. Karger AG, Basel
Introduction
In a monochorionic-diamniotic pregnancy, an imbal-
anced blood flow between the 2 fetuses can lead to twin-
to-twin transfusion syndrome (TTTS) [1]. In almost all 
placentas of monochorionic twin pregnancies, anasto-
moses are found; nevertheless, TTTS only occurs in 10–
15% [2]. The risk of fetal death of one or both twins is 
above 90% without treatment [3]. Fetoscopic laser coagu-
lation of anastomoses is the only causal therapy and rep-
resents the gold standard since Senat et al. [4] presented 
higher survival rates and a better neurological outcome 
after laser therapy than sole amniotic fluid reduction [4].
Several studies have presented survival rates after feto-
scopic laser surgery (FLS) of 70–90% for at least 1 child 
and approximately 40–70% for 2 children [4–8]. Due to 
the improving survival rates, the main interest is shifting 
from survival to the long-term outcome and the neuro-
logical development of the surviving children. Several 
studies showed that the incidence of cerebral injury is 
lower after FLS than after sole amnion reduction [4, 9, 
10]. A meta-analysis from van Klink et al. [10] even 
showed a 7-fold higher incidence of severe cerebral in-
jury in TTTS twins treated with amnion reduction than 
in TTTS twins treated with FLS.
The aims of this study were to analyze the long-term 
outcome of children treated with FLS, including their 
school career, the need for special therapy or special aid 
equipment, and their free-time activities, and compare 
their outcome to that of dichorionic twins. An under-
standing of the development of the children over time will 
provide a more accurate counselling to parents who are 
diagnosed with TTTS during pregnancy. Further, the 
long-term outcome is also an important quality control 
when performing fetoscopic surgery.
Material and Methods
Study Population
From 2008 to 2017, a total of 70 FLSs were performed at the 
Zurich Center for Fetal Diagnosis and Therapy Hospital of Zurich 
(www.swissfetus.ch). Fifty-seven FLSs were performed due to 
TTTS. Eligible for the laser group in this retrospective cohort study 
were children who were treated by FLS and were at least 6 months 
old. Further inclusion criteria that regarded both the FLS and the 
control groups were good German language skills and parental 
informed consent. Thirty-two women could not be included due 
to either loss of pregnancy (n = 12), neonatal death (n = 1), loss of 
follow-up or insufficient German language skills (n = 15), still 
pregnant or children younger than 6 months (n = 3), and refusal 
(n = 1). Ultimately, 25 women and 42 children were included as 
the “laser group” (Fig. 1).
The control group included dichorionic twins matched for 
birth year (±2 years), gestational age (GA; ±3 weeks), birth weight, 
and sex. All baseline data were collected from the electronic hos-
pital charts of the mothers and their infants. The following vari-
ables were collected from the clinical records: maternal age, parity, 
ethnicity, and socioeconomic status, defined by a validated 
12-point score based on maternal education and paternal occupa-
tion – the higher the score, the lower the socioeconomic class, ac-
cording to Largo et al. [11].
Pregnancy Course
TTTS was diagnosed based on ultrasound criteria by Quintero 
et al. [12]. Fetoscopic laser coagulation of the placental anastomo-
ses was performed under regional anesthesia in the first 10 cases 
and under local anesthesia with analgosedation in the following 47 
cases. A fetoscope was inserted through a 10 French trocar through 
the abdominal wall into the amniotic cavity under constant ultra-
sound guidance. The anastomoses were selectively coagulated by 
a YAG laser. Always the same 2 feto-maternal specialists per-
formed the FLS under ultrasound guidance. The Solomon tech-
nique [13] has been performed since 2011.
Outcome Parameter
The primary outcome of this analysis was the event-free long-
term development of the children. Within event-free survival, the 
main focus was set on the neurodevelopmental outcome. An 
event-free long-term outcome was defined for children who were 
free of any neurological or behavioral abnormality, and no severe 
visual or hearing deficiencies.
The neurological outcomes included cerebral palsy (CP), epi-
lepsy, and other sensorimotor deficiencies. CP was clinically diag-
nosed and classified according to the recommendations of the Eu-
ropean Cerebral Palsy Network [14]. Sensorimotor abnormalities 
included isolated abnormal tone, reflexes, or coordination, which 
did not meet the criteria for CP.
Outcome evaluation also included the behavioral develop-
ment of the children, which was assessed using the Strengths and 
Difficulties Questionnaire (SDQ) filled out by the parents. Chil-
dren with a GA or weight at birth below 32 weeks or 1,500 g, re-
spectively, were also assessed by means of the Bayley Scales of 
Infant Development, second edition (BSID-II) [15], and Bayley 
Scales of Infant and Toddler Development, third edition (Bayley-
III) [16], as part of the Swiss Follow-up Program for very preterm 
infants.
The secondary outcomes were school career (including diffi-
culties in school, such as repeating a school year, need for educa-
tional support, speech, and writing), special therapy and require-
ment of special aid or other assistive equipment, and free-time 
activities of the children, as assessed by a generic parental ques-
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tionnaire. Both primary and secondary outcomes were compared 
with dichorionic-diamniotic twins, to assess if they differ from 
twins with TTTS and laser surgery during pregnancy.
Maternal and Neonatal Course
The following neonatal baseline data of the infants were also col-
lected from the computerized medical records: GA, weight, length, 
head circumference, umbilical cord pH, and Apgar scores at deliv-
ery. The data on the major neonatal morbidities known to be associ-
ated with a poor long-term outcome in preterm infants [17] were 
also collected from the database of the department. These included 
bronchopulmonary dysplasia, necrotizing enterocolitis, sepsis, reti-
nopathy of prematurity defined as previously published [17], and 
major brain injury, defined by cerebral ultrasound exam as cystic 
periventricular leukomalacia and/or intraventricular hemorrhage 
grade 3 or higher according to the classification of Papile [18].
Pediatric Course and Long-Term Outcome
Data on the development of the study children were collected by 
means of a parental questionnaire including a short survey about 
their children’s general health, medication, school situation, therapy 
(e.g., physiotherapy and speech therapy), any kind of support (e.g., 
glasses, hearing aid, or walking aid). The parent version of the SDQ 
was used to assess the behavioral outcome of the study children [19]. 
The SDQ is a standardized parental, teacher, or self-report question-
naire on behavioral problems of children and adolescents [20, 21]. 
The SDQ consists of 5 sections with 5 questions each, resulting in a 
total number of 25 questions. Each answer is scored on a scale rang-
ing from 0 (= not true) to 2 (= certainly true). The 5 sections screen 
for the following behavioral domains: emotional symptoms (e.g., 
Item 24: “Many fears, easily scared…”), conduct problems (e.g., 
Item 18: “Often lies or cheats”), hyperactivity/inattention (e.g., Item 
10: “Constantly fidgeting or squirming”), peer problems (e.g., Item 
19: “Picked on or bullied by other children”), and prosocial behavior 
(e.g., Item 4: “Shares readily with other children”) [19, 20]. Each do-
main corresponds to a subscale that is computed by adding the 
scores of all answers of the same section and ranges 0–10 points, 
with higher scores indicating more behavioral problems. The pro-
social scale shows a reverse direction with lower scores indicating a 
worse behavioral pattern. Excluding the prosocial scale, the scores 
for emotional problems, conduct problems, hyperactivity/inatten-
tion, and peer relationship problems are summed up to a “total dif-
ficulties score,” which ranges from 0 to 40. The “total difficulties 
scores” ranging from 0 to 13 are classified as normal, scores ranging 
14–16 are considered borderline, and scores above 16 are considered 
abnormal. We combined children in the borderline and abnormal 
categories into a single “at-risk” category, as we considered the bor-
derline group also to be at risk for behavioral problems.
All children born before 32 gestational weeks or with a birth 
weight lower than 1,500 g were registered into the National Regis-
try of the Swiss Neonatal Network. A pediatrician specialized in 
development examined these children at the age of 2 and 5 years. 
Their neurological development was assessed using the BSID-II 
[15] (between 2006 and 2012) or Bayley-III [16] (afterward). The 
study was approved by the Ethics Committee Zurich (KEK-ZH 
No. 2017-01268). Written informed consent was obtained from 
the parents of each child.
Statistics
Quantitative data are presented as medians with minimum and 
maximum values, or mean ± SD. Percentages are given for the re-
sults of categorical variables. The Shapiro-Wilk test was performed 
to check for normal distribution. The t-test or Mann-Whitney U 
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Fig. 1. FLS, fetoscopic laser surgery; TTTS, twin-to-twin transfusion syndrome.
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tions when the theoretical numbers were >5, and Fisher’s exact test 
was used when the theoretical numbers were <5.
Univariate and multivariate logistic regression analyses were 
performed to identify independent predictors for event-free sur-
vival. Odds ratio and 95% confidence intervals were provided. A p 
value <0.05 was considered statistically significant. The statistical 
analysis was performed using SPSS (IBM SPSS Statistics version 
22, Zurich, Switzerland).
Results
For the long-term outcome, we had data from 25 
mothers and 42 children treated with laser therapy and 16 
mothers with 32 children in the control group. When 
comparing the included and excluded children, there was 






Age at time of assessment, months 50 (7–111) 60 (31–116) 0.14
Event-free survival, n (%) 32 (76) 24 (75) 0.91
Neurological anomalies, n (%) 5 (12) 3 (9) 1.0
CP, n (%) 2 (5) 0 (0) 0.5
Epilepsy, n (%) 1 (2) 0 (0) 1.0
Other SM findings, n (%) 3 (7) 3 (9) 1.0
SDQ test, n (%) N = 39 N = 28
Values ≥14 (at risk) 4 (10) 1 (4) 0.39
Bayley test (II or III), n (%)a N = 15 N = 16
Values <85 4 (27%) 7 (44%) 0.32
Values <70 2 (13%) 3 (19%) 1.0
SM, sensorimotor; SDQ, Strengths and Difficulties Questionnaire; GW, gestational 
weeks; CP, cerebral palsy. a Children born before 32 GW or/and with a birth weight low-
er than 1,500 g.
Table 1. Event-free survival and 
neurological long-term outcome
Table 2. Detailed information about the children with neurological findings
Case Baseline (birth weight, birth 






Cranial ultrasound SDQ Mental/motor 
development in the 
BSID II or III
Neurological 
finding
1 (L) Male, 890 g, 33.5 cm, 1-3-3 1 26 3/7 Normal Normal Normal SM 
abnormalities
2 (L) Male, 1,650 g, 42.5 cm, 4-66 3 31 5/7 Hemorrhage grade I, cystic leukomalacia 
grade II, contralateral ischemia
18 BSID II: 50/49 CP, epilepsy
3 (L) Male, 950 g, 36 cm, 6-8-8 3 31 5/7 Normal Normal BSID II: 68/77 SM 
abnormalities
4 (L) Female, 990 g, 36 cm, 5-7-8 1 30 1/7 Normal Normal Normal SM 
abnormalities
5 (L) Female, 1,280 g, 39 cm, 8-6-8 3 28 6/7 Increased periventricular echogenicity Normal BSID III: 125/112/– CP
1 (C) Female, 650 g, 29.5 cm, 7-10-10 – 31 0/7 Germinolysis Normal BSID II: 106/84 SM 
abnormalities
2 (C) Female, 1,150 g, 37 cm, 8-8-9 – 28 6/7 Normal Normal BSID II: 94/84 SM 
abnormalities
3 (C) Female, 1,260 g, 40 cm, 7-9-9 – 29 5/7 Dilated lateral ventricles 14 BSID II: 86/84 SM 
abnormalities
1 (L) Laser coagulation had to be terminated due to bleeding, and IUFD occurred. 2 (L) and 3 (L) are siblings. L, Laser; C, Control; SDQ, Strengths and 
Difficulties Questionnaire; BSID, Bayley Scales of Infant Development, version II or III, normative value for each score 100±15; CP, cerebral palsy; SM, sen-
sorimotor; GA, gestational age; GW, gestational weeks.
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due to loss of follow-up or insufficient German language 
skills regarding GA at birth (p = 0.19), birth weight (p = 
0.11), or 5-min Apgar (p = 0.09). There was a significant 
difference in GA at birth in cases where pregnancy was 
lost (p < 0.001) compared to the included cases. Maternal 
age was similar in all included and excluded cases (p = 
0.76).
For the control group, we had questionnaires filled out 
by the parents from 22 children, and in the remaining 10 
children, we had the data from the Registry of the Swiss 
Neonatal Network. This explains why in some cases the 
SDQ (questionnaire) and in other cases the BSID-II 
(Swiss Neonatal Network) are listed. The secondary end-
points such as school career, special therapy or require-
ment of special aid or other assistive equipment, and free-
time activities of the children were also assessed with the 
questionnaire filled out by the parents.
Primary Outcome
Table 1 presents the event-free survival rates and the 
neurological long-term outcome of the children. Event-
free survival, neurodevelopmental long-term outcome, 
and behavioral outcome were similar in both groups. In 
the laser group, there were 2 children with CP – one of 
them was also diagnosed with epilepsy. Of the 76% chil-
dren with an event-free survival, 40% were initially diag-
nosed with Quintero 1 or 2 and 36% with Quintero 3 or 
4. There was no statistically significant difference in the 
event-free survival according to Quintero stages within 
the laser group (p = 0.7).
Detailed information about the 8 children with neuro-
logical findings is presented in Table 2. In cases 1, 3, and 
4 of the laser group and in case 2 of the control group, the 
cranial ultrasound controls were normal at the time of as-
sessment.
A univariate regression analysis was performed and 
identified GA at delivery (p < 0.001), birth weight (p = 
0.004), birth length (0.003), and Apgar score at 5 min 
(0.016) as possible independent predictive factors for an 
event-free survival. The multiple logistic regression anal-
ysis showed that only GA at delivery was a predictive fac-
tor for event-free survival (p = 0.044) (Table 3).
Maternal and neonatal baseline characteristics of the 
laser group and the control group are shown in Table 4. 
Table 3. Multiple regression analysis
Mean ± SD N (%) p value
















OR (95% CI) p value
GA at delivery, GW 1.73 (1.01–2.94) 0.044
GA, gestational age; GW, gestational weeks.
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Neonatal characteristics (N = 42) (N = 32)
GA at delivery, GW 32.8±3.0 32.85±3.6 0.95
Weight, g 1,888±741 1,714±702 0.31
Length, cm 42.2±4.7 41.6±5.3 0.63
Head circumference, cm 30.3±3.4 29.8±3.3 0.60
Umbilical artery-pH 7.30±0.06 7.31±0.06 0.58
Apgar, 5 min 8 (3–10) 9 (3–10) 0.08
Sex (female), n (%) 26 (62) 17 (53) 0.45
Neonatal complications, n (%)
RDS 28 (67) 17 (53) 0.24
NEC 2 (5) 0 (0) 0.50
Sepsis 3 (7) 1 (3) 0.62
ROP 1 (2) 0 (0) 1.0
Oxygen >36 days 4 (10) 1 (3) 0.37
Brain lesion 1 (2) 0 (0) 1.0
Death within first 
30 days of life, n (%) 0 (0) 0 (0) –
GA, gestational age; GW, gestational weeks; RDS, respiratory 
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Eleven children were initially classified as Quintero 1, 12 
as Quintero 2, 17 as Quintero 3, and 2 as Quintero 4. 
There was no significant difference in the neonatal base-
line characteristics or the perinatal morbidity between the 
2 groups.
Secondary Outcome
School Career, Therapy, and Need for Special Aid 
Equipment
Information on school career, need for special therapy, 
or requirement of special aid equipment is shown in Ta-
ble 5. There was no significant difference between the la-
ser and the control group. No child of both groups re-
peated a class, and only 4 children (10%) of the laser 
group needed remedial teaching (p = 0.13). The most fre-
quent therapy was physical therapy in both groups (26 vs. 
31%, p = 0.63). Five children in the laser group (12%), but 
none in the control group, required special aid equipment 
(p = 0.16).
Free-Time Activities
The children in the control group had more hobbies 
than the children in the laser group (86 vs. 57%, p = 0.018). 
The most frequent sports were gymnastics, swimming, 
soccer, and other ball sports such as volleyball or tennis. 
Skiing, horseback riding, kung fu, and karate were also 
mentioned. The musically active children either played 
an instrument (piano, flute, or violin) or were singing in 
a choir. More children from the laser group needed a 
break during sports than children in the control group 
(21 vs. 0%, p = 0.02), and fewer children from the laser 
group were able to keep up while doing sports (69 vs. 
100%, p = 0.003).
Discussion
The present study shows that the rate of event-free 
long-term outcome, including school career, therapies, or 
special aid equipment, in monochorionic twins after FLS 
is comparable to that of dichorionic twins who did not 
have any invasive intervention during pregnancy and that 
only the GA at delivery seems to be a predictive factor for 
event-free survival. Overall, neurological anomalies were 
found in 12% in the laser group and in 9% in the control 
group. CP was diagnosed in 5% of the laser group. Chil-
dren without FLS were involved in more free-time activi-
ties and needed fewer breaks during physical activity than 
children with FLS during pregnancy.
The presented results are comparable to other interna-
tional studies. Banek et al. [22] also studied the long-term 
neurodevelopmental outcome of twins after intrauterine 
laser surgery for TTTS. The 89 children included in their 
study underwent physical and neurological examination; 
78% of the children showed normal development, 11% 
had minor neurological anomalies, and another 11% had 
major neurological deficiencies. Also, Lenclen et al. [9] 
studied the neurodevelopmental outcome of children af-
ter laser therapy. The children were assessed at 2 years of 
age corrected for prematurity. The assessment was per-
formed using an Ages and Stages Questionnaire (ASQ) 
and a neurological assessment [9]. They compared the 
neurological outcome and the results of the ASQ with a 
group of dichorionic children. Considering the neurolog-
ical impairment, there was no significant difference be-
tween the children treated with FLS and dichorionic chil-
dren; the rate for normal neurological development was 
88.6 and 93.6%, respectively [9]. They also found that low 
GA was the only significant factor associated with neuro-
logical impairment in twins treated with laser therapy due 
to TTTS [9]. Lopriore et al. [23] compared monochori-
onic twins with TTTS and laser therapy with monochori-
onic twins without TTTS. They described a significant 
higher incidence of severe cerebral lesions in twins with 
Table 5. School career, special therapy, and special aid equipment
School career Laser group 
(N = 42), n (%)
Control group 
(N = 22a), n (%)
p 
value
No schoola 24 (57) 12 (55) 0.84
Kindergartena 7 (17) 2 (9) 0.47
Schoola 11 (26) 8 (36) 0.40
Skip a classa 0 (0) 0 (0) –
Remedial teachinga 4 (10) 0 (0) 0.29
Special schoola 0 (0) 0 (0) –
Language schoola 0 (0) 0 (0) –
Therapy 12 (29) 13 (41) 0.28
Speech therapy 2 (5) 1 (3) 0.56
Physical therapy 11 (26) 10 (31) 0.63
Psychomotoric 
therapy 1 (2) 0 (0) 1.0
Early support/
education 4 (10) 0 (0) 0.13
Curative education 2 (5) 2 (6) 1.0
Special aidsa 5 (12) 0 (0) 0.16
Hearing aida 0 (0) 0 (0) –
Glassesa 3 (7) 0 (0) 0.56
Walking aida 2 (5) 0 (0) 0.54
Splinta 1 (2) 0 (0) 1.0
a Only answered in questionnaire, available for 22 children in 
the control group.
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TTTS than in monochorionic twins without TTTS (10 vs. 
2%, p = 0.02) [23].
In a review, van Klink et al. [24] discusses results on 
the long-term outcome of TTTS survivors, treated with 
either amnioreduction or FLS. For the FLS group, they 
analyzed 13 studies from 1999 to 2015 [24]. Their num-
bers for CP ranged from 2% to 12%, which are also com-
parable to our findings (2 children, 5%). They mentioned 
a higher Quintero stage as a risk factor for neurodevelop-
mental impairment [24]. We, on the other hand, did not 
find a difference between Quintero stages 1 and 2 and 3 
and 4 within the laser group.
Another current systematic review from Miralles-
Gutiérrez et al. [25], which included 9 studies with sample 
sizes ranging from 56 to 318, described a mean incidence 
of neurological anomalies at 24 months of age after laser 
therapy in 14%. CP was described in about 6% of the chil-
dren treated with laser therapy [25]. The children in our 
group were older at the time of assessment (24 months 
[25] vs. 50 months), but the results are similar. The review 
from Miralles-Gutiérrez et al. [25] did not find a clear cor-
relation between neurological complications and a higher 
Quintero stage.
Hack et al. [26] also compared the long-term neurode-
velopmental outcome of monochorionic twins with 
matched dichorionic twins. They used the same following 
matching criteria: GA at delivery, gender, birth weight, 
and ethnicity [26]. They also did not describe any signifi-
cant differences between the monochorionic and dicho-
rionic twins except a slight delay in language and hearing 
development in monochorionic twins [26].
There was no significant difference regarding school 
career, need of special therapy, or requirement of special 
aid equipment in our cohort. Physical therapy was the 
most frequent therapy in both groups. The only differ-
ences between the 2 groups were that children from the 
control group were participating in more free-time ac-
tivities and needed less breaks during physical activity 
than children from the laser group. These observations 
can be explained by the fact that control children were 
older than children in the laser group at the assessment 
period, and so possibly were already more involved in 
after-school activities. While these 2 findings could be re-
lated to a reduced physical endurance of children in the 
laser group in comparison with controls, the absence of a 
difference regarding the event-free survival between the 
2 groups does not support this hypothesis. Since reports 
on this outcome in similar cohorts as in our study are 
lacking, no comparison of these findings with data from 
the literature is possible.
van Klink et al. [27] compared the neurodevelopmen-
tal outcome at 2 years between twins with TTTS treated 
with either the Solomon technique or standard laser sur-
gery. They also compared early interventions such as 
physical therapy, speech-language therapy, and psycho-
logical interventions between the 2 groups. There were no 
significant differences in the mentioned early interven-
tions between the 2 groups [27]. Physical therapy was per-
formed in 39% for the Solomon group and 41% for the 
standard group [27]; 9 and 12% needed speech-language 
therapy [27]. In our laser group, 26% of the children 
needed physical therapy and in 5% speech therapy was 
necessary. School career was comparable in both groups. 
Children without FLS were involved in more free-time 
activities and needed fewer breaks during physical activ-
ity than children with FLS during pregnancy. We found 
no studies that looked at school career and children’s 
free-time activities.
Limitations
The small sample size of the laser and the control 
group, a selection bias due to the excluded cases, and the 
retrospective design of the analysis are the 3 main limita-
tions of this study, which could have limited the general-
izability of the results.
Strengths
The strength of this study is the analysis of the long-
term outcome after laser therapy, including their school 
career, need for therapy and special aid equipment, and 
free-time activities, and not only the survival rates of the 
children in a well-monitored Swiss cohort. The knowl-
edge of their school career and their leisure time activities 
is an important part in counselling parents who are diag-
nosed with TTTS during pregnancy. To our knowledge, 
this is the only study that also compared parameters such 
as school career, therapies, need for special aid equip-
ment, and leisure time activities between children treated 
with FLS and their control group, consisting of twins and 
not only singleton pregnancies.
Conclusion
In the present study sample, the outcome of monocho-
rionic twins treated with FLS was comparable to the out-
come of dichorionic twins without invasive treatment. 
Long-term neurodevelopmental outcome in the cohort 
was mainly dependent on GA at birth.
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